Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting

2010154 citationsJournal Articlebronze Open Access

Authors

Marta Durán · Sociedad Española de Farmacología Clínica

E. Pérez · Universitat Autònoma de Barcelona

Sergio Abanades · Municipal Institute for Medical Research

Xavier Vidal · Universitat Autònoma de Barcelona

Cristina Saura · Vall d'Hebron Hospital Universitari

Margarita Majem · Hospital de Sant Pau

Edurne Arriola

Abstract

Compared with placebo, CBM added to standard antiemetic therapy was well tolerated and provided better protection against delayed CINV. These results should be confirmed in a phase III clinical trial.

Topics & Keywords

Cannabis and Cannabinoid Research Restless Legs Syndrome Research Nausea and vomiting management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Clinical Pharmacology

Volume 70, Issue 5, pp. 656-663

DOI: 10.1111/j.1365-2125.2010.03743.x

Field-Weighted Citation Impact: 2.95